Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation

AIMS: Warfarin, a vitamin K antagonist (VKA), has been the standard of care for stroke prevention in patients with atrial fibrillation (AF). Aspirin is recommended for low-risk patients and those unsuitable for warfarin. Apixaban is an oral anticoagulant that has demonstrated better efficacy than wa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dorian, Paul, Kongnakorn, Thitima, Phatak, Hemant, Rublee, Dale A., Kuznik, Andreas, Lanitis, Tereza, Liu, Larry Z., Iloeje, Uchenna, Hernandez, Luis, Lip, Gregory Y.H.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Basic Science
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104492/
https://ncbi.nlm.nih.gov/pubmed/24513791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items